Hepatitis C virus inhibitors

Details for Australian Patent Application No. 2010234608 (hide)

Owner Bristol-Myers Squibb Company

Inventors Belema, Makonen; Kadow, John F.

Agent A J Park

Pub. Number AU-A-2010234608

PCT Pub. Number WO2010/117977

Priority 61/167,989 09.04.09 US

Filing date 6 April 2010

Wipo publication date 14 October 2010

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4178 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/117977 Priority application(s): WO2010/117977

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234610-Serotonin and norepinephrine reuptake inhibitor

2010234607-Spray-dried blood products and methods of making same